Beta receptor antagonism in hypertension; comparison with the effect of adrenergic neurone inhibition on cardiovascular responses.
D000328:Adult; D001794:Blood Pressure; D002986:Clinical Trials as Topic; D005260:Female; D005542:Forearm / Q000098:blood supply; D006145:Guanethidine / Q000627:therapeutic use*; D006146:Guanidines / Q000627:therapeutic use*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008297:Male; D008750:Methyldopa / Q000627:therapeutic use*; D008875:Middle Aged; D005082:Physical Exertion; D011433:Propranolol / Q000494:pharmacology / Q000627:therapeutic use*; D011674:Pulse; D012039:Regional Blood Flow; D013696:Temperature; D014636:Valsalva Maneuver
D006146:Guanidines; D008750:Methyldopa; D011433:Propranolol; D006145:Guanethidine